|
|
| | Gefitinib N-Oxide Basic information |
| Product Name: | Gefitinib N-Oxide | | Synonyms: | Gefitinib N-Oxide;4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine 4-oxide;Gefitinib impurities137;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-oxido-4-morpholinyl)propoxy]-;Gefitinib nitrogen oxide impurity;Gefitinib-3;4-(3-((4-((3-chloro-4- fluorophenyl)amino)-;4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine 4-oxide hydrochloride | | CAS: | 847949-51-3 | | MF: | C22H24ClFN4O4 | | MW: | 462.9 | | EINECS: | | | Product Categories: | | | Mol File: | 847949-51-3.mol |  |
| | Gefitinib N-Oxide Chemical Properties |
| | Gefitinib N-Oxide Usage And Synthesis |
| Uses | Gefitinib Morpholine N-oxide is the N-oxide derivative of Gefitinib (G304000); a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). |
| | Gefitinib N-Oxide Preparation Products And Raw materials |
|